Starts & Stops: Edwards Gets FDA OK To Study CardioValve, Enrollment Complete In Medtronic Spinal-Stim Trial
Executive Summary
Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by Meddevicetracker. This edition covers trial announcements made Sept. 24 through Sept. 30, including trial announcements from Medtronic, Cardis, Edwards Lifesciences, CARDIS, and Cefaly Technologies.